Yonge-Eglinton Laser Center, Department of Ophthalmology, Toronto Western Hospital, University Health Network, Toronto, ON.
Can J Ophthalmol. 2013 Jun;48(3):173-8. doi: 10.1016/j.jcjo.2013.02.001.
To compare combined intrastromal corneal ring segment implantation with same-day ultraviolet-A/riboflavin corneal collagen cross-linking (ICRS-CXL) versus ICRS implantation alone in patients with corneal ectasia.
Retrospective comparative study.
Sixty-six eyes from 54 patients with corneal ectasia were included in the study. The groups were composed of 32 eyes from 27 patients and 34 eyes from 27 patients for the ICRS-CXL and ICRS groups, respectively.
We reviewed the charts of all patients who underwent these procedures from November 2008 to February 2011 for preoperative and for up to 1 year postoperative uncorrected (UDVA) and best corrected distance visual acuity (BDVA), refraction, topographical analysis (mean and steepest keratometry [K]), as well as root mean-square (RMS) of higher-order aberrations (HOAs).
Overall, a significant improvement was seen in both groups for UDVA, BDVA, sphere, cylinder, mean refractive spherical equivalent (MRSE), mean and steepest K, coma, spherical and total HOA at 12 months. Trefoil did not improve, and higher-order astigmatism worsened in the ICRS group (p = 0.0466). There was no statistically significant difference between the 2 groups for visual acuity, sphere, cylinder, coma, trefoil, and spherical HOA. Outcomes were significantly more improved in the ICRS group for MRSE (p = 0.0082), mean K (p = 0.0021), steepest K (p = 0.0152), and total HOAs (p = 0.0208). No complications were observed.
ICRS-CXL and ICRS alone were both safe and effective in treating corneal ectasia. The ICRS alone group demonstrated better outcomes of MRSE, mean and steepest K, as well as total HOA.
比较联合角膜基质内环形片段植入术与当日紫外线 A/核黄素角膜胶原交联术(ICRS-CXL)与单独 ICRS 植入术治疗角膜扩张症的效果。
回顾性比较研究。
本研究纳入 54 例角膜扩张症患者的 66 只眼。两组分别由 27 例患者中的 32 只眼和 27 例患者中的 34 只眼组成,即 ICRS-CXL 组和 ICRS 组。
我们回顾了 2008 年 11 月至 2011 年 2 月期间所有接受这些手术的患者的图表,记录术前和术后 1 年的未矫正(UDVA)和最佳矫正距离视力(BDVA)、屈光度、地形图分析(平均和最陡角膜曲率[K])以及高阶像差(HOAs)的均方根(RMS)。
总体而言,两组患者的 UDVA、BDVA、球镜、柱镜、平均屈光球镜等效(MRSE)、平均和最陡 K、彗差、球镜和总 HOAs 在 12 个月时均有显著改善。在 ICRS 组中,三叶草形并未改善,高阶散光恶化(p = 0.0466)。两组间视力、球镜、柱镜、彗差、三叶草形和球镜 HOAs 无统计学差异。在 ICRS 组中,MRSE(p = 0.0082)、平均 K(p = 0.0021)、最陡 K(p = 0.0152)和总 HOAs(p = 0.0208)的结果改善更为显著。未观察到并发症。
单独 ICRS-CXL 和 ICRS 治疗角膜扩张症均安全有效。单独 ICRS 组在 MRSE、平均和最陡 K 以及总 HOAs 方面的结果更好。